Method for producing a computational reduction vaccine

A method for producing a computational reduction vaccine, comprising:

• a. Computationally analyzing a virus or bacterium to identify mathematically significant fragments within the organism;
• b. Determining the frequency and consistency of the identified fragments across a genetic database of similar organisms;
• c. Selecting fragments for removal based on their mathematical significance and frequency;
• d. Using CRISPR or a similar genetic engineering tool to remove the selected fragments from a “Super-Organism,” which is a host organism containing all or most of the identified fragments, thereby creating a “neutered” version of the organism;
• e. Testing the “neutered” version of the organism to ensure it no longer possesses problematic functions, including but not limited to high transmissibility or mortality;
• f. Utilizing the “neutered” organism as a basis for a vaccine candidate, wherein the vaccine provokes an immune response in a recipient while the problematic functions of the original pathogen are disabled by the reduction process;
• g. Utilizing the DNA fragments or mRNA transcriptions of the DNA fragments identified in a) and b) as a basis for a vaccine candidate, wherein these fragments might be the actual problematic functions but are separated from other genetic machinery of the pathogen which might otherwise make those functions problematic;
• h. The vaccine produced by the method of claim 1 being selected from a live attenuated vaccine, an inactivated vaccine, or a composition of mathematically significant DNA or mRNA transcripts.